Vilvet Pharmaceutical Draws FDA Warning for Quality Violations

Drug Industry Daily
A A
The FDA hit Pennsylvania drugmaker Vilvet Pharmaceutical with a warning letter for quality violations at its Chester Springs facility.

To View This Article:

Login

Subscribe To Drug Industry Daily